$AMBS In April 2017, Amarantus Bioscience Holdings (“AMBS” or the “Company”) made the strategic decision to house our various assets in individual subsidiaries to raise focused capital in order to move the assets forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.